GovChime
Notice ID: ab497678af0b448491afd65b291b031fPresolicitationArchived

Thermo Fisher Scientific (Life Technologies) Reagents and Consumable Materials for Cell Therapy Manufacturing

Archived on August 21, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
8:00 AM EDT
Posted
August 11, 2026
Notice type
Presolicitation
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Bethesda, Maryland, 20892
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
26-008602
Notice ID
ab497678af0b448491afd65b291b031f

Description

NOTICE OF INTENT TO SOLE SOURCE

Thermo Fisher Scientific (Life Technologies)
Reagents and Consumable Materials for Cell Therapy Manufacturing

Agency

Department of Health and Human Services (HHS), National Institutes of Health (NIH), Clinical Center

Program Office

Center for Cellular Engineering (CCE), Department of Transfusion Medicine

Notice Type

Notice of Intent to Sole Source

Proposed Source

Thermo Fisher Scientific (Life Technologies)

Response Due

August 20, 2026 at 8:00 AM Eastern Time

DESCRIPTION

The National Institutes of Health (NIH), Clinical Center, Center for Cellular Engineering (CCE) intends to award a firm-fixed-price contract on a sole-source basis to Thermo Fisher Scientific (Life Technologies) for reagents and consumable materials used in the manufacture of cell-based therapies for patients enrolled in clinical trials at the NIH Clinical Center.

REQUIRED MATERIALS

Description/Part No./Quantity

AIM V MED CTS 1000ML/0870112DK/12 Bottles

DYNABEADS CD3/CD28 CTS 10 ML/40203D/3 Vials

CTS AIM-V MEDIUM MINUS 1000ML/A3830801/12 Each

ACK LYSING BUFFER 100ML/A1049201/20 Bottles

RPMI 1640 100ML/11875101/25 Bottles

CTS AIM-V MEDIUM MINUS 10L/A3830802/4 Each

SOLE-SOURCE RATIONALE

CCE manufactures cell-based therapies under FDA-regulated current Good Manufacturing Practice (cGMP) conditions. The required Thermo Fisher Scientific (Life Technologies) reagents and consumable materials have been validated for CCE's manufacturing processes and approved by the CCE Quality Assurance Department. Substitution of these materials would require extensive requalification and validation of manufacturing processes, resulting in additional cost, significant time delays, and potential delays to patient treatment. Thermo Fisher Scientific (Life Technologies) can provide the required materials and quantities in a timely manner with the supporting documentation necessary for use in an FDA-regulated manufacturing process.

The Government intends to proceed under the authority cited in the supporting justification, 41 U.S.C. 3304(a)(1), for an acquisition available from only one responsible source where no other supplies will satisfy the agency's requirements.

CAPABILITY STATEMENTS / RESPONSE INSTRUCTIONS

This notice is not a request for competitive quotations. However, all responsible sources that believe they can satisfy the Government's requirement may submit a written capability statement demonstrating their ability to provide the exact required materials, quantities, and supporting documentation without causing revalidation of CCE's established manufacturing processes. Responses must contain sufficient technical information for the Government to determine whether the respondent can meet the requirement. Please reference number 26-008602 when submitting capability statements and submit them by the due date to shasheshe.goolsby@nih.gov. 

Responses are due no later than August 20, 2026 at 8:00 AM Eastern Time.

Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government. The Government will not reimburse respondents for costs associated with preparing or submitting a response.

Interested parties should submit their capability statement through the point of contact identified in the SAM.gov notice. The response should reference this Notice of Intent and the Thermo Fisher Scientific (Life Technologies) CCE reagents and consumable materials requirement.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    Thermo Fisher Scientific (Life Technologies) Reagents and Consumable Materials for Cell Therapy Manufacturing

    Notice ab497678af0b448491afd65b291b031f on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

26-008602

Archive Date

Aug 21, 2026

Office Address

BETHESDA, MD, 20892